Back to Search
CHANDRAKANT SHAH, M.D.
M.D.
Cardiovascular Disease Physician
NPI: 1114939105Individual
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
C51128(CA)
Research & Publications (20)
Amrubicin: a synthetic anthracyclin analogue in the treatment of extensive stage small cell lung cancer.
PMID 19538159·Recent Pat Anticancer Drug Discov·2009
6-review
Factors affecting risk of mortality in women with vaginal cancer.
PMID 19384118·Obstet Gynecol·2009
8-other
Imaging biomarkers predict response to anti-HER2 (ErbB2) therapy in preclinical models of breast cancer.
PMID 19584166·Clin Cancer Res·2009
7-preclinical
Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.
PMID 18359942·J Biol Chem·2008
7-preclinical
Intratumoral T cells, tumor-associated macrophages, and regulatory T cells: association with p53 mutations, circulating tumor DNA and survival in women with ovarian cancer.
PMID 18314181·Gynecol Oncol·2008
8-other
The impact of development of acute lung injury on hospital mortality in critically ill trauma patients.
PMID 18664786·Crit Care Med·2008
8-other
Ambulance response time and emergency medical dispatcher program: a study in Kelantan, Malaysia.
PMID 19062707·Southeast Asian J Trop Med Public Health·2008
8-other
Granulocytic sarcoma in a patient with myelodysplastic syndrome.
PMID 18709903·Oncology (Williston Park)·2008
5-case
A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer.
PMID 17399850·Lung Cancer·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1555 VIVALDI ST
CARDIFF BY THE SEA, CA 92007 - Phone
- (760) 633-3044
Quick Facts
- NPI
- 1114939105
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile